TickerFacts.

Tenax Therapeutics, Inc. (TENX): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2016-12-31
$219.2K2011-04-30: $219.2K2012-04-30: $51.3K2013-04-30: $43.1K2014-04-30: $129.8K2015-04-30: $02016-12-31: $0$0
2011-04-30 Cost of Revenue (USD) 2016-12-31
Period endedCost of RevenueChange YoYSource filing
2016-12-31$0n/a2017-03-16, From 2016-01-01
No annual figure between 2015-04-30 and 2016-12-31.
2015-04-30$0-100.0%2017-03-16, From 2014-05-01
2014-04-30$129.8K+201.1%2017-03-16, From 2013-05-01
2013-04-30$43.1K-15.9%2014-07-29, From 2012-05-01
2012-04-30$51.3K-76.6%2013-06-26, From 2011-05-01
2011-04-30$219.2Kn/a2012-07-25, From 2010-05-01